New weapons against superbugs: trial tests promising antibiotic combos

NCT ID NCT05905055

Summary

This study tested two new antibiotic combinations (cefepime/nacubactam and aztreonam/nacubactam) against the best available treatments for serious, drug-resistant bacterial infections. It involved 126 hospitalized adults with infections like pneumonia, urinary tract infections, or abdominal infections that were resistant to common antibiotics. The goal was to see if the new combinations could successfully cure these difficult-to-treat infections.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLICATED INTRA-ABDOMINAL INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Meiji Research Site

    Changsha, China

  • Meiji Research Site

    Chongqing, China

  • Meiji Research Site

    Fuyang, China

  • Meiji Research Site

    Guangzhou, China

  • Meiji Research Site

    Hangzhou, China

  • Meiji Research Site

    Hefei, China

  • Meiji Research Site

    Nanjing, China

  • Meiji Research Site

    Nanning, China

  • Meiji Research Site

    Quanzhou, China

  • Meiji Research Site

    Shanghai, China

  • Meiji Research Site

    Shenzhen, China

  • Meiji Research Site

    Shijiazhuang, China

  • Meiji Research Site

    Wuxi, China

  • Meiji Research Site

    Xuzhou, China

  • Meiji Research Site

    Zagreb, Croatia

  • Meiji Research Site

    Kyjov, Czechia

  • Meiji Research Site

    Limoges, France

  • Meiji Research Site

    Nîmes, France

  • Meiji Research Site

    Paris, France

  • Meiji Research Site

    Strasbourg, France

  • Meiji Research Site

    Kutaisi, Georgia

  • Meiji Research Site

    Tbilisi, Georgia

  • Meiji Research Site

    Zestaponi, Georgia

  • Meiji Research Site

    Athens, Greece

  • Meiji Research Site

    Be’er Ya‘aqov, Israel

  • Meiji Research Site

    Ramat Gan, Israel

  • Meiji Research Site

    Tel Aviv, Israel

  • Meiji Research Site

    Nankoku, Kochi, Japan

  • Meiji Research Site

    Hiroshima, Japan

  • Meiji Research Site

    Kanazawa, Japan

  • Meiji Research Site

    Nagasaki, Japan

  • Meiji Research Site

    Nankoku, Japan

  • Meiji Research Site

    Ōta-ku, Japan

  • Meiji Research Site

    Shinjuku-ku, Japan

  • Meiji Research Site

    Toyoake, Japan

  • Meiji Research Site

    Daugavpils, Latvia

  • Meiji Research Site

    Liepāja, Latvia

  • Meiji Research Site

    Riga, Latvia

  • Meiji Research Site

    Valmiera, Latvia

  • Meiji Research Site

    Nitra, Slovakia

  • Meiji Research Site

    Svidník, Slovakia

  • Meiji Research Site

    Córdoba, Spain

  • Meiji Research Site

    Madrid, Spain

  • Meiji Research Site

    Kaohsiung City, Taiwan

  • Meiji Research Site

    Taichung, Taiwan

  • Meiji Research Site

    Taipei, Taiwan

  • Meiji Research Site

    Bangkok, Thailand

  • Meiji Research Site

    Chiang Mai, Thailand

  • Meiji Research Site

    Khon Kaen, Thailand

  • Meiji Research Site

    Ankara, Turkey (Türkiye)

  • Meiji Research Site

    Eskişehir, Turkey (Türkiye)

  • Meiji Research Site

    Istanbul, Turkey (Türkiye)

  • Meiji Research Site

    İzmit, Turkey (Türkiye)

  • Meiji Research Site

    Trabzon, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.